GR3001809T3 - Benzylaminoaryldihydropyridine lactones, process for their preparation and their use in medicaments - Google Patents

Benzylaminoaryldihydropyridine lactones, process for their preparation and their use in medicaments

Info

Publication number
GR3001809T3
GR3001809T3 GR91400475T GR910400475T GR3001809T3 GR 3001809 T3 GR3001809 T3 GR 3001809T3 GR 91400475 T GR91400475 T GR 91400475T GR 910400475 T GR910400475 T GR 910400475T GR 3001809 T3 GR3001809 T3 GR 3001809T3
Authority
GR
Greece
Prior art keywords
benzylaminoaryldihydropyridine
lactones
medicaments
preparation
circulation
Prior art date
Application number
GR91400475T
Other languages
English (en)
Inventor
Siegfried Dr Goldmann
Rainer Prof Dr Gross
Martin Dr Bechem
Michael Dr Kayser
Matthias Dr Schramm
Siegbert Dr Hebisch
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of GR3001809T3 publication Critical patent/GR3001809T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR91400475T 1987-02-26 1991-04-18 Benzylaminoaryldihydropyridine lactones, process for their preparation and their use in medicaments GR3001809T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873706204 DE3706204A1 (de) 1987-02-26 1987-02-26 Benzylaminoaryl-dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
GR3001809T3 true GR3001809T3 (en) 1992-11-23

Family

ID=6321825

Family Applications (1)

Application Number Title Priority Date Filing Date
GR91400475T GR3001809T3 (en) 1987-02-26 1991-04-18 Benzylaminoaryldihydropyridine lactones, process for their preparation and their use in medicaments

Country Status (14)

Country Link
US (1) US4904665A (el)
EP (1) EP0281789B1 (el)
JP (1) JP2647413B2 (el)
KR (1) KR880009967A (el)
AT (1) ATE62688T1 (el)
AU (1) AU600798B2 (el)
CA (1) CA1304375C (el)
DE (2) DE3706204A1 (el)
DK (1) DK98788A (el)
ES (1) ES2037116T3 (el)
GR (1) GR3001809T3 (el)
HU (1) HU198211B (el)
IL (1) IL85508A (el)
ZA (1) ZA881322B (el)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3410645A1 (de) * 1984-03-23 1985-09-26 Bayer Ag, 5090 Leverkusen L-alkylsubstituierte 1,4-dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3600596A1 (de) * 1986-01-11 1987-07-16 Bayer Ag 4-aminoaryldihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
ES2037116T3 (es) 1993-06-16
JPS63227589A (ja) 1988-09-21
IL85508A (en) 1991-11-21
DK98788A (da) 1988-08-27
DE3862404D1 (de) 1991-05-23
JP2647413B2 (ja) 1997-08-27
ATE62688T1 (de) 1991-05-15
EP0281789A1 (de) 1988-09-14
IL85508A0 (en) 1988-08-31
DK98788D0 (da) 1988-02-25
US4904665A (en) 1990-02-27
HUT47286A (en) 1989-02-28
ZA881322B (en) 1988-08-23
CA1304375C (en) 1992-06-30
DE3706204A1 (de) 1988-09-08
EP0281789B1 (de) 1991-04-17
HU198211B (en) 1989-08-28
KR880009967A (ko) 1988-10-06
AU1239788A (en) 1988-09-01
AU600798B2 (en) 1990-08-23

Similar Documents

Publication Publication Date Title
ZA895090B (en) Novel benzopyran derivatives,processes for their preparation and their use and preparations containing the compounds
JPS6429362A (en) 3-demethylmevalonic acid derivative
AU580973B2 (en) Novel polypeptides with an ``-amylase-inhibiting action, a process for their preparation, their use and pharmaceutical products
EP0387821A3 (de) 2-Alkyl-4-arylmethylaminochinoline, ihre Verwendung und daraus hergestellte Arzneimittel
ES8607271A1 (es) Amidinohidrazonas
IL87490A0 (en) Pharmaceutical compositions containing 2-pyrimidinyl-1-piperazine derivatives for the treatment of alcoholism
DE3567211D1 (en) (pyrrol-1-yl)-phenyl-dihydropyridazinones, their preparation and use
EP0331092A3 (en) Alpha-amino-carboxylic-acid derivatives, their preparation and use
KR960004860B1 (en) Substituted pyridine-2,4-dicarboxylic acid compounds and the use thereof and medicaments
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
ES8707734A1 (es) Procedimiento para la obtencion de cefalosporinas
AU553874B2 (en) Thiazaspirane derivatives
EP0234348A3 (en) N-glycosyl amide derivatives, method for their preparation and their use as medicaments
ZA874470B (en) New tetrahydrobenzothiazoles,and the preparation and use thereof
DE3463143D1 (en) 1-0-alkyl-3-amino-propan-1.2-diol-2-0-phospholipids, process for producing the same and pharmaceutical preparations containing the same
PT87563A (pt) Process for the preparation of vinylcephalosporins useful as medicaments
ZA881322B (en) Benzylaminoaryl-dihydropyridinelactones,process for their preparation,and their use in medicaments
GR3005231T3 (el)
DE3264007D1 (en) 5,6-dihydro-11-alkylene-morphantridin-6-ones, process for their preparation and pharmaceutical preparations containing them
HUT44802A (en) Process for producing pseudo-oligosaccharides and pharmaceutical compositions containing them
ES8800666A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidropiridina
ZA885337B (en) Leukotriene antagonists,a process for the preparation thereof,and the use thereof for the treatment of diseases
ES8606298A1 (es) 1.4-dihidropirazinas
EP0292820A3 (en) 3-phenyl-2-styryl-pyrrolidines, their preparation and use